ANDREA CORBISHLEY: Open Payments
NPI 1972613925 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 66 payments from 19 companies in 2025. Trend: 2023 $1,797 · 2024 $1,590 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $240 |
| Lilly USA, LLC | 10 | $186 |
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| Astellas Pharma US Inc | 6 | $104 |
| Abbott Laboratories | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $97 |
| ABBVIE INC. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 3 | $46 |
Products named: AIRSUPRA, PREVNAR 20, MOUNJARO, Veozah, FREESTYLE LIBRE 3, Kerendia, NURTEC ODT, KISUNLA.
Industry payments across OK — which companies pay providers there.
